Platelet sodium/hydrogen exchanger activity in normotensives and hypertensives

Clinica Chimica Acta

Volumn 283, Issue 1-2, 1999, Pages 105-118

  Sagnella, G A ^a   Miller, M A ^a   Khong, T K ^a   MacGregor, G A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acid excretion; Hypertension; Platelets; Sodium hydrogen exchanger

Indexed keywords

ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; MALE; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; THROMBOCYTE;

ADULT; BLOOD PLATELETS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERTENSION; KINETICS; MALE; MIDDLE AGED; REFERENCE VALUES; SODIUM-HYDROGEN ANTIPORTER;

EID: 0032768720     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00041-8     Document Type: Article

References (23)

1. Rosskopf D., Dusing R., Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension. 21:1993;607-617.
2. + exchange in the pathophysiology of essential hypertension. Am J Hypertens. 9:1996;703-707.
3. + exchange rates in essential hypertension: application of a novel test. Lancet. 1:1987;533-536.
4. Schmouder R.L., Weder A.B. Platelet sodium-proton exchange is increased in essential hypertension. J Hypertens. 7:1989;323-330.
5. + exchanger activity in normotensive and hypertensive subjects: effect of enalapril therapy upon antiport activity. J Hypertens. 10:1992;839-847.
6. Doktor H.S., Benjamin N., Todd S.D., et al. Sodium dependence of sodium-proton exchange in platelets from patients with essential hypertension. J Hum Hypertens. 5:1991;161-165.
7. Tokudome G., Tomonari H., Gardner J.P., et al. Variations in the apparent pH set point for activation of platelet Na-H antiport. Hypertension. 16:1990;180-189.
8. O'Brien E., Petrie J., Littler W., et al. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens. 11:1993;677-679.
9. Miller M.A., Sagnella G.A., Markandu N.D., et al. Determinants of platelet intracellular free calcium in essential hypertension and effect of stimulation by arginine vasopressin. Am J Hypertens. 6:1993;209-216.
10. + antiport in human fibroblasts and platelets. Proc Soc Exp Biol Med. 194:1990;165-171.
11. Roos A., Boron W.F. Intracellular pH. Physiol Rev. 61:1981;296-434.
12. + exchanger. Clin Sci. 79:1990;531-536.
13. Boyarsky G., Hanssen C., Clyne L.A. Superiority of in vitro over in vivo calibrations of BCECF in vascular smooth muscle cells. FASEB J. 10:1996;1205-1212.
14. Miller M.A., Sagnella G.A., MacGregor G.A. Extraction method and nonextracted kit method compared for measuring plasma aldosterone. Clin Chem. 43:1997;1995-1997.
15. Gende O.A., Cingolani H.E. Identification of a sodium-bicarbonate symport in human platelets. Biochim Biophys Acta. 1278:1996;119-124.
16. + exchanger in human platelets. FEBS Lett. 277:1990;235-238.
17. Trevisan R., Viberti G. Sodium-hydrogen antiporter: its possible role in the genesis of diabetic nephropathy. Nephrol Dial Transplant. 12:1997;643-645. Editorial.
18. + antiport: activation in primary hypertension and during chronic NaCl-loading. Eur J Clin Invest. 24:1994;529-539.
19. + exchange rate and more alkaline intracellular pH set-point in essential hypertension: effect of protein kinase modulation in platelets. J Hypertens. 9:1991;1013-1019.
20. + exchange in platelets of patients with essential hypertension using an optical swelling assay. J Hypertens. 9:1991;231-238.
21. Stratton P.D., Ritter J.M. Influence of sex on sodium-proton exchange-dependent swelling of platelets from patients with essential hypertension. J Hypertens. 15:(12 Pt 1):1997;1403-1406.
22. + exchanger in essential hypertension. Kidney Int. 45:1994;1037-1043.
23. Rowe W.A., Blackmon D.L., Montrose M.H. Propionate activates multiple ion transport mechanisms in the HT29-18-Cl human colon cell line. Am J Physiol. 265:1993;G564-G571.